Comparing the Effect of Neostigmine and Metoclopramide on Gastric Residual Volume of Mechanically Ventilated Patients in Intensive Care Unit: A Double-Blind Randomized Clinical Trial.
Alireza Rahat-DahmardehSahar Saeedi MoghaddamMasoum Khosh-FetratPublished in: BioMed research international (2021)
According to the results, although neostigmine treatment significantly improved GRV in more patients in less time, within 12 hours of treatment, all patients in both groups had complete recovery. Considering that there was no significant difference between the two groups in terms of side effects, it seems that both drugs are effective in improving the GRV of ICU patients.
Keyphrases
- end stage renal disease
- intensive care unit
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- clinical trial
- patient reported
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- combination therapy
- smoking cessation
- replacement therapy
- double blind